CASP8 and Stroke: Since the repair process for damaged brain tissues and regeneration of neural cells takes place during resolution of inflammation [17], and having demonstrated that active caspase-8 is mostly confined to reactive myeloid cells in the peri-infarct region, we anticipate that site-directed delivery of caspase-8 inhibitors under stroke conditions may hinder microglia activation and affect microglia survival.